Media Coverage

COVID-19 Oral Pill Therapeutic Vaccine Found Promising in Early Study
January 18, 2021
(Precision Vaccinations)
New York-based Key Capital Corporation announced independent laboratory testing of its partnered Immunitor COVID-19 patented oral pill vaccine in an ongoing university study is providing promising early support for the safety and efficacy of the vaccine.
Read More »

Phase III, placebo-controlled, randomized, double-blind trial
February 1, 2020
Phase III, placebo-controlled, randomized, double-blind trial of tableted, therapeutic TB vaccine (V7) containing heat-killed M. vaccae administered daily for one month.
Read More »

Interim results
January 7, 2020
Interim results from ongoing Phase III placebo-controlled, randomized trial of hepcortespenlisimut-L for advanced hepatocellular carcinoma indication.
Read More »